In simpler terms, it seeks to move away from a "one-size-fits-all" approach to medicine and instead aims to deliver precision medicine by predicting:2
A person's genes contain instructions for making proteins, including enzymes that metabolize (break down) drugs and receptors that drugs bind to.6 Variations in these genes can affect:
By analyzing a patient's DNA (often from a blood sample or cheek swab), healthcare providers can identify these genetic variations and use that information to make more informed treatment decisions.12
Pharmacogenomics is already used in several areas of medicine, including:13
The core distinction lies in the number of genes being studied.
⚖️ Pharmacogenetics vs. Pharmacogenomics
| Feature |
Pharmacogenetics |
Pharmacogenomics |
| Focus |
Single Gene-Drug Interaction |
Entire Genome-Drug Interaction |
| Scope |
Narrower. It studies how variation in one or a few specific genes affects the response to a single drug. |
Broader. It studies how the entire genome (all of a person's genes) influences a person's response to an entire class of drugs or treatment overall. |
| Etymology |
Pharmaco + Genetics (the study of heredity and single genes). |
Pharmaco + Genomics (the study of all genes/the whole genome). |
| Goal |
To understand the mechanism of a specific drug interaction (e.g., how a patient breaks down a particular drug). |
To develop a holistic, personalized treatment plan that maximizes efficacy and minimizes toxicity across many drugs. |
💡 Simple Analogy
Think of it like this:
-
Pharmacogenetics is like looking at one engine part ($CYP2D6$ enzyme) to see how it affects a single car's performance (how a specific antidepressant works).
-
Pharmacogenomics is like looking at the entire car's blueprint (all the patient's genes) to understand how it will perform on the road, including interactions with fuel, environment, and other parts, which helps in predicting the outcome of all related medications in the future.
In modern research and clinical practice, the trend is to use the broader term, pharmacogenomics, because technologies like next-generation sequencing often analyze many genes simultaneously, making the comprehensive, "whole-genome" approach more common.